Debunking Myths: What’s Holding Back In Silico Innovation in Cardiovascular Devices
As regulatory frameworks evolve and digital health technologies advance, in silico methods like modeling, simulation, and virtual clinical trials are increasingly positioned to transform cardiovascular device development. In silico clinical trials for cardiovascular devices are high on the list of priorities for regulators such as FDA. Still, despite clear advantages, …
Debunking Myths: What’s Holding Back In Silico Innovation in Cardiovascular Devices Read More »